REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Monday broker round-up

Mon, 10th May 2021 13:05

(Sharecast News) - St Modwen: Liberum downgrades to hold with a target price of 542p.



Marlowe: Berenberg reiterates buy with a target price of 900p.

Midwich Group: Berenberg reiterates buy with a target price of 620p.

IAG: Berenberg reiterates buy with a target price of 230p.

Air Partner: Canaccord reiterates buy with a target price of 100p.

Begbies Traynor Group: Canaccord reiterates buy with a target price of 170p.

Hotel Chocolat: Liberum reiterates buy with a target price of 600p.

Dignity: Peel Hunt reiterates sell with a target price of 450p.

On The Beach: Peel Hunt reiterates buy with a target price of 500p.

Meggitt: Citigroup reiterates neutral with a target price of 430p.

Berkeley Group: JP Morgan reiterates overweight with a target price of 5,400p.

AstraZeneca: Deutsche Bank reiterates buy with a target price of 10,200p.

London Stock Exchange: Credit Suisse reiterates outperform with a target price of 8,500p.

Related Shares

More News
Today 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemi...

Today 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was ...

7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announ...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.